Grant: Alliance Grants
McGill University
$50,000.00
Anti-viral fabric coatings for high effectiveness personal protective equipment (Covid-19)_x000d_ _x000d_ _x000d_ _x000d_ _x000d_ _x000d_
FY 2020-21
Summary
SARS-CoV-2 spreads by inhalation or by mucous contact with virus-contaminated droplets. In addition to social distancing, masks and gloves have become increasingly recommended not just for healthcare and essential workers but also for the general public. High-efficacy masks (e.g. surgical masks or N95 masks) and medical gloves, while effective in limited duration, cannot be produced at scale for the whole population and health care providers from all over the world have made desperate pleas to secure adequate supplies of personal protection equipment (PPE).
Here we propose a series of antiviral coatings to be applied easily and stably to fabric. The coatings would kill the virus upon contact, and could be applied both by healthcare workers on low-efficacy masks to make them equivalent to N95 masks or higher, and by the general public, on scarves or gloves that they may already own. The coatings would thus minimize infections through both droplet inhalation or hand-to-face transmission. The coatings we propose are inexpensive, scalable, nontoxic, easy to deposit and will have long-lasting antiviral effect. Blachford Ltd is a world leading chemical material producer with great expertise in formulation of suspensions, thickeners, and dispersions. They are our partner as they are highly interested in our approach and in the commercialization of our results. During this project they will provide both scientific input on coating formulation and regulatory and marketing consultations: while working on the chemistry of the coatings and testing them for antiviral properties, we will understand the regulatory requirements that coatings will need to comply to, and the marketing/production constraints. This fully integrated approach that includes scientific development, production vision and regulatory understanding will allow us to deliver a product that can be brought to the public very soon. This is crucial given the urgency of the pandemic and the benefits that the proposed coatings will bring to the population in terms of being able to go back to a less restricted life, and to the healthcare workers as a way to solve the current drastic shortage of PPE.
Program
Alliance Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
555215-2020
Name nom
Cerruti, Marta
Department département
Mining & Materials Engineering.
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
2004
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Polymers and coatings
Research subject fr
Polymères et revêtements
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Anti-viral fabric coatings for high effectiveness personal protective equipment (Covid-19)_x000d_
_x000d_
_x000d_
_x000d_
_x000d_
_x000d_
Keyword
NSERC
Application summary
SARS-CoV-2 spreads by inhalation or by mucous contact with virus-contaminated droplets. In addition to social distancing, masks and gloves have become increasingly recommended not just for healthcare and essential workers but also for the general public. High-efficacy masks (e.g. surgical masks or N95 masks) and medical gloves, while effective in limited duration, cannot be produced at scale for the whole population and health care providers from all over the world have made desperate pleas to secure adequate supplies of personal protection equipment (PPE).
Here we propose a series of antiviral coatings to be applied easily and stably to fabric. The coatings would kill the virus upon contact, and could be applied both by healthcare workers on low-efficacy masks to make them equivalent to N95 masks or higher, and by the general public, on scarves or gloves that they may already own. The coatings would thus minimize infections through both droplet inhalation or hand-to-face transmission. The coatings we propose are inexpensive, scalable, nontoxic, easy to deposit and will have long-lasting antiviral effect. Blachford Ltd is a world leading chemical material producer with great expertise in formulation of suspensions, thickeners, and dispersions. They are our partner as they are highly interested in our approach and in the commercialization of our results. During this project they will provide both scientific input on coating formulation and regulatory and marketing consultations: while working on the chemistry of the coatings and testing them for antiviral properties, we will understand the regulatory requirements that coatings will need to comply to, and the marketing/production constraints. This fully integrated approach that includes scientific development, production vision and regulatory understanding will allow us to deliver a product that can be brought to the public very soon. This is crucial given the urgency of the pandemic and the benefits that the proposed coatings will bring to the population in terms of being able to go back to a less restricted life, and to the healthcare workers as a way to solve the current drastic shortage of PPE.